Sodium Bicarbonate 4 % & 8.5% Injection
PDF Leaflet Revision Date: 17 June 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Correction of metabolic acidosis.
Dosage (summary)
Administer diluted solutions intravenously; initial doses should be small to avoid overtreatment.
Special Populations
- Renal impairment
- Neonates
- Elderly
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Corticosteroids
- Potassium depleting diuretics
- Acidic medications
Contraindications
- Hypersensitivity
- Renal failure
- Metabolic alkalosis
- Hypoventilation
Common side effects
- Metabolic alkalosis
- Hypokalaemia
- Muscle weakness
- Shortness of breath
Counselling Points
- Dilute before use
- Monitor electrolytes
- Avoid rapid infusion in neonates
Serious warnings
- Risk of fluid overload
- Chemical cellulitis from extravasation
- Monitor acid-base status
Important Disclaimer
The Sodium Bicarbonate 4 % & 8.5% Injection professional information leaflet below is the property of Fresenius Kabi Manufacturing Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
